靶向CD45的正电子发射断层扫描（PET）能够实现炎症状态的可视化。
CD45-targeted PET enables the visualization of inflammatory conditions.
作者信息
Li Chongjiao, Song Zhendong, Hu Qilong, Li Yinlong, Patel Jimmy S, Liang Steven H
机构信息
Department of Radiology and Imaging Sciences, Emory University Atlanta, Georgia 30322, USA.
出版信息
Am J Nucl Med Mol Imaging. 2025 Jun 25;15(3):124-129. doi: 10.62347/VFWR2835. eCollection 2025.
Abstract
Inflammation is a major contributor to human mortality, accounting for over 50% of deaths worldwide. Therefore, there is an urgent need for early and accurate diagnostic methods. PET imaging targeting leukocyte common antigen CD45 presents a promising approach for detecting inflammation and monitoring therapeutic responses.
摘要
炎症是导致人类死亡的主要因素，全球超过50%的死亡病例与之相关。因此，迫切需要早期准确的诊断方法。靶向白细胞共同抗原CD45的正电子发射断层扫描（PET）成像为检测炎症和监测治疗反应提供了一种很有前景的方法。
相似文献
1
CD45-targeted PET enables the visualization of inflammatory conditions.
Am J Nucl Med Mol Imaging. 2025 Jun 25;15(3):124-129. doi: 10.62347/VFWR2835. eCollection 2025.
2
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.
Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD010533. doi: 10.1002/14651858.CD010533.pub2.
3
The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Health Technol Assess. 2011 Sep;15(35):1-192, iii-iv. doi: 10.3310/hta15350.
4
Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
Health Technol Assess. 2013 Mar;17(12):1-323. doi: 10.3310/hta17120.
5
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
Eur Urol Oncol. 2022 Aug;5(4):390-400. doi: 10.1016/j.euo.2022.04.006. Epub 2022 Jun 15.
6
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
7
The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature.
Minerva Urol Nefrol. 2018 Oct;70(5):462-478. doi: 10.23736/S0393-2249.18.03081-3. Epub 2018 Apr 17.
8
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.
Health Technol Assess. 2011 Jan;15(4):iii-iv, 1-134. doi: 10.3310/hta15040.
9
Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.
Cochrane Database Syst Rev. 2021 Nov 9;11(11):CD012325. doi: 10.1002/14651858.CD012325.pub2.
10
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3.
本文引用的文献
1
Exendin-4 imaging based on gastrointestinal GLP-1R targets for IBD diagnosis and efficacy assessment.
Eur J Nucl Med Mol Imaging. 2025 Apr 3. doi: 10.1007/s00259-025-07197-z.
2
CD45-PET is a robust, non-invasive tool for imaging inflammation.
Nature. 2025 Mar;639(8053):214-224. doi: 10.1038/s41586-024-08441-6. Epub 2025 Jan 22.
3
Trends in nanobody radiotheranostics.
Eur J Nucl Med Mol Imaging. 2025 May;52(6):2225-2238. doi: 10.1007/s00259-025-07077-6. Epub 2025 Jan 13.
4
Role of Total Body PET/CT in Inflammatory Disorders.
Semin Nucl Med. 2025 Jan;55(1):41-51. doi: 10.1053/j.semnuclmed.2024.11.001. Epub 2024 Nov 21.
5
Visualizing Immune Checkpoint Inhibitors Derived Inflammation in Atherosclerosis.
Circ Res. 2024 Oct 25;135(10):990-1003. doi: 10.1161/CIRCRESAHA.124.324260. Epub 2024 Sep 27.
6
F-FDG-PET/MR imaging to monitor disease activity in large vessel vasculitis.
Nat Commun. 2024 Aug 25;15(1):7314. doi: 10.1038/s41467-024-51613-1.
7
CXCR4-Targeted 68 Ga-Pentixafor PET/CT Imaging in Inflammatory Bowel Disease.
Clin Nucl Med. 2024 Sep 1;49(9):817-821. doi: 10.1097/RLU.0000000000005374. Epub 2024 Jul 31.
8
Granzyme B PET Imaging for Assessment of Disease Activity in Inflammatory Bowel Disease.
J Nucl Med. 2024 Jul 1;65(7):1137-1143. doi: 10.2967/jnumed.123.267344.
9
PSMA-Targeted PET Radiotracer [F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease.
Clin Exp Gastroenterol. 2023 Dec 8;16:237-247. doi: 10.2147/CEG.S404009. eCollection 2023.
10
Imaging Agents for PET of Inflammatory Bowel Disease: A Review.
J Nucl Med. 2023 Dec 1;64(12):1858-1864. doi: 10.2967/jnumed.123.265935.
Zotero 插件